Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a dedicated Locations section with Massachusetts and Ohio sites and updated the revision tag to v3.3.3.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedThe revision label on the page updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedDeleted the notice about government funding lapse and NIH Clinical Center operating status. The page no longer directs readers to opm.gov for operating status updates.SummaryDifference0.3%

- Check64 days agoChange DetectedNo content-level changes to core study details or eligibility criteria were detected; any detected differences appear to be minor UI/layout adjustments that do not affect the page's purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check100 days agoChange DetectedUpdated page content scope to include Multiple myeloma and bumped revision to v3.1.0, replacing the earlier specific topic (Plasma cell myeloma) and older version tag (v3.0.2).SummaryDifference0.4%

Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.